Welcome to our dedicated page for Earth Science Te SEC filings (Ticker: ETST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Earth Science Tech, Inc. (ETST) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Earth Science Tech is a Florida corporation whose common stock trades on the Over the Counter Bulletin Board under the symbol ETST and is registered under Section 12(g) of the Securities Exchange Act of 1934, as noted in its 8-K reports.
Through these filings, investors can review how Earth Science Tech documents material events and corporate actions tied to its role as a strategic holding company in the healthcare and pharmaceutical sectors. Recent Form 8-K filings describe, among other items, the company’s directive to update its industry classification to SIC 2834 (Pharmaceutical Preparations), its engagement with an investor relations firm, and its qualification for the OTCID tier. Another 8-K details an amendment to the Articles of Incorporation reducing authorized common shares from 350,000,000 to 300,000,000, reflecting share structure decisions approved via shareholder consent and corporate resolutions.
While this page focuses on current and historical SEC submissions, Stock Titan enhances usability with AI-powered summaries that help explain the significance of filings without altering their content. As new documents are posted to EDGAR, such as additional 8-Ks or other periodic reports, they are captured here with real-time updates so users can quickly see changes related to regulatory status, capital structure, and strategic announcements referenced in company press releases.
Investors researching ETST can use this resource to understand how Earth Science Tech reports its pharmaceutical classification, OTC market status, and governance decisions, and to connect those disclosures with its broader operations in compounding pharmacies, telemedicine, real estate development, and consumer brands.
Earth Science Tech, Inc. reports the launch of MyOnlineConsultation.com through its MOCTeledoc, LLC division, completing what it describes as a fully vertically integrated telehealth and pharmacy ecosystem. MOCTeledoc is introduced as a doctor network that provides both technology and clinical staffing to digital health companies.
The company states that MOCTeledoc was cash-flow-positive during its beta phase and is expected to be immediately accretive to earnings as it is rolled out nationwide. Management highlights that offering the custom telehealth platform and prescriber network as a turnkey service creates a new revenue stream and a funnel to Earth Science Tech’s in-house compounding pharmacies.
The filing also reiterates that Earth Science Tech is a diversified health and wellness holding company operating compounding pharmacies, telemedicine platforms, targeted healthcare facilities, a real estate and asset management arm, a consumer products brand, and a non-profit foundation supporting patient prescription costs.
Earth Science Tech, Inc. reported that on March 11, 2026 it mutually agreed to renew the employment agreements of Chief Financial Officer Ernesto L. Flores and Chief Technology Officer Christopher A. Rose for an additional one-year term.
The original agreements were entered into on March 11, 2025, and all other material terms and conditions remain unchanged and in full force and effect.
Earth Science Tech, Inc. reported a change in its independent auditor. On February 17, 2026, Stephano Slack LLC resigned as the company’s independent registered public accounting firm. Its prior audit reports for the year ended March 31, 2025 contained no adverse opinions, disclaimers, or qualifications.
The company states there were no disagreements or reportable events with Stephano Slack under SEC Regulation S-K during the referenced periods. Also on February 17, 2026, Earth Science Tech engaged Semple, Marchal & Cooper, LLP as its new independent PCAOB auditor for the fiscal year ending March 31, 2026 and issued a press release describing this engagement.
Earth Science Tech, Inc. reported a strong third fiscal quarter 2026 with revenue of $8.4 million, up 14.1% year-over-year, and gross margin expanding to 76.3% from 69.2%. Net income jumped to $910,000 from $206,000, while Adjusted EBITDA rose to $1.2 million from $0.3 million.
The Company highlighted improving balance sheet quality, with total assets of $8.1 million, working capital of $773,000, no bank debt, and 3.7 million shares repurchased and retired over nine months. Multiple operating units are generating positive cash flow, and Peaks, its telemedicine platform, surpassed $2.0 million in revenue in under a year.
Management and the Board announced governance and cost initiatives expected to deliver approximately $1.4 million in annualized savings, supporting an increase in net income from about $3.3 million in fiscal 2025 to a projected $4.7 million in fiscal 2026. Actions include voiding CEO and COO employment contracts, waiving variable pay in the interim, reducing Board meeting fees to $2,000, planning a non-binding say-on-pay vote, evaluating retirement of Series B preferred stock, and targeting divestiture of non-core assets.
Earth Science Tech, Inc. reported stronger results for the quarter ended December 31, 2025. Revenue for the quarter rose to $8.39 million from $7.35 million, lifting gross profit to $6.40 million and expanding gross margin to 76% from 69%. Net income for the quarter increased to $0.91 million from $0.21 million, while nine-month net income grew to $2.31 million from $2.08 million on revenue of $26.20 million versus $24.44 million. Total assets reached $8.09 million with liabilities of $2.29 million and stockholders’ equity of $5.80 million. Operating cash flow was $1.06 million for the nine months, with cash declining to $0.42 million after investment spending and share repurchases. The company continued building its healthcare and telemedicine platform through the acquisitions of Las Villas Health, DOConsultations, and 80% of Magnefuse, and repurchased about 3.7 million shares for $0.65 million.
Earth Science Tech, Inc. filed a current report to disclose that it has issued a press release about an industry classification update. On January 6, 2026, the company announced a directive industry classification update to Standard Industrial Classification (SIC) code 2834, which is used for pharmaceutical-related entities. The disclosure notes that the company has formally identified as a pharmaceutical entity since 2022. The press release describing this classification update is included as an exhibit to the report.
Earth Science Tech, Inc. reported that on January 5, 2026 it issued a press release announcing its engagement with Hayden IR. The company furnished this update as an "Other Event" and attached the full press release as Exhibit 99.1 to provide additional detail about the new engagement.
Earth Science Tech, Inc. (ETST) filed an 8-K announcing it issued a press release sharing results for the period ended September 30, 2025. The disclosure is furnished under Item 7.01 (Regulation FD) and is not deemed “filed” for purposes of Section 18, nor incorporated by reference unless expressly stated. Exhibit 99.1 contains the press release, and Exhibit 104 provides the cover page Inline XBRL data. The report was signed by Giorgio R. Saumat, CEO and Chairman.
Earth Science Tech, Inc. (ETST) filed its Q2 FY2026 10‑Q, reporting higher sales and profits. For the quarter ended September 30, 2025, revenue was $9,050,626 with gross profit of $6,723,984 (74% margin). Net income was $945,897, or $0.003 per share. For the six months, revenue reached $17,810,816, gross profit $12,814,758 (71% margin), and net income $1,402,611 ($0.005 per share).
The balance sheet showed total assets of $8,667,416 and stockholders’ equity of $5,075,823. Cash was $1,235,374. Operating cash flow was $1,181,196, offset by investing cash outflows of $940,788 and financing cash outflows of $478,262.
The company continued its buyback program, repurchasing 1,510,000 shares in the quarter for $282,370, and 2,560,296 shares year‑to‑date for $469,428. Subsequent to quarter‑end, 744,603 additional shares were repurchased. ETST completed acquisitions on April 1, 2025 (Las Villas Health and DOConsultations for $200,000; 80% of Magnefuse for $240,500), and recorded related goodwill. As of October 29, 2025, common shares outstanding were 292,407,607 and preferred shares were 1,000,000.
Earth Science Tech (ETST) amended its Articles of Incorporation to reduce its authorized common stock, lowering the limit from 350,000,000 to 300,000,000 shares. The change was approved by majority shareholder written consent and a corporate resolution on August 19, 2025, and the State of Florida stamped and uploaded the amendment on October 10, 2025.